Semi‐quantitative detection showed that mifepristone‐treated adenomyosis group significantly decreased the expression of CXCR4 in both eutopic and ectopic endometriums when compared to mifepristone‐untreated group (Figure 5B). Here, CXCR4 is linked to adenomyosis.